Robbins Geller $94M Fee In Pfizer Suit Too High, Judge Told
Robbins Geller Rudman & Dowd LLP is getting greedy with its $94 million fee request in a $400 million settlement with Pfizer Inc., one of the investor plaintiffs complained to a New...To view the full article, register now.
Already a subscriber? Click here to view full article